1. Campbell, N., Boustani, M. A., Ayub, A., Fox, G. C., Munger, S. L., Ott, C., Guzman, O., Farber, M., Ademuyiwa, A., & Singh, R. (2009). Pharmacological management of delirium in hospitalized adults: A systematic evidence review. Journal of General Internal Medicine, 24(7), 848–853.
2. Chen, R., & Young, G. B. (1996). Metabolic encephalopathies. In C. F. Bolton & G. B. Young (Eds.), Baillere’s clinical neurology. London: Balliere Tindall.
3. Earnest, M. P., & Parker, W. D. (1993). Metabolic encephalopathies and coma from medical causes. In J. Grotta (Ed.), Management of the acutely ill neurological patient. New York: Churchill Livingstone.
4. Ely, E. W., Shintani, A., Truman, B., Speroff, T., Gordon, S. M., Harrell, F. E., Inouye, S. K., Bernard, G., & Dittus, R. S. (2004a). Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA, 291, 1753–1762.
5. Ely, E. W., Stephens, R. K., Jackson, J. C., Thomason, J. W., Truman, B., Gordon, S., Dittus, R., & Bernard, G. (2004b). Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: A survey of 912 healthcare professionals. Critical Care Medicine, 32(1), 106–112.